Business Description
Tissue Regenix Group PLC
ISIN : GB00BNTXR104
Description
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.5 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.31 | |||||
| Debt-to-EBITDA | 21.03 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -0.59 | |||||
| Beneish M-Score | -2.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.2 | |||||
| 3-Year EPS without NRI Growth Rate | 41.3 | |||||
| 3-Year Book Growth Rate | -6.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 92.85 | |||||
| 9-Day RSI | 67.28 | |||||
| 14-Day RSI | 51.74 | |||||
| 6-1 Month Momentum % | 12.2 | |||||
| 12-1 Month Momentum % | 14.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.03 | |||||
| Quick Ratio | 1.84 | |||||
| Cash Ratio | 0.98 | |||||
| Days Inventory | 259.95 | |||||
| Days Sales Outstanding | 52.5 | |||||
| Days Payable | 58.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -0.12 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.61 | |||||
| Operating Margin % | -1.33 | |||||
| Net Margin % | -5.81 | |||||
| FCF Margin % | 0.58 | |||||
| ROE % | -5.51 | |||||
| ROA % | -3.78 | |||||
| ROIC % | -1.03 | |||||
| ROC (Joel Greenblatt) % | -2.7 | |||||
| ROCE % | -1.34 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.86 | |||||
| PB Ratio | 1.83 | |||||
| Price-to-Tangible-Book | 3.66 | |||||
| Price-to-Free-Cash-Flow | 309.73 | |||||
| Price-to-Operating-Cash-Flow | 51.62 | |||||
| EV-to-EBIT | -113.49 | |||||
| EV-to-Forward-EBIT | 53.9 | |||||
| EV-to-EBITDA | 135.03 | |||||
| EV-to-Forward-EBITDA | 24.59 | |||||
| EV-to-Revenue | 2.04 | |||||
| EV-to-Forward-Revenue | 1.72 | |||||
| EV-to-FCF | 339.19 | |||||
| Price-to-Median-PS-Value | 0.26 | |||||
| Price-to-Net-Current-Asset-Value | 8.69 | |||||
| Earnings Yield (Greenblatt) % | -0.88 | |||||
| FCF Yield % | 0.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tissue Regenix Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 27.129 | ||
| EPS (TTM) (€) | -0.023 | ||
| Beta | 0 | ||
| Volatility % | 32.8 | ||
| 14-Day RSI | 51.74 | ||
| 14-Day ATR (€) | 0.002471 | ||
| 20-Day SMA (€) | 0.69025 | ||
| 12-1 Month Momentum % | 14.62 | ||
| 52-Week Range (€) | 0.555 - 0.875 | ||
| Shares Outstanding (Mil) | 70.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tissue Regenix Group PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tissue Regenix Group PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tissue Regenix Group PLC Frequently Asked Questions
What is Tissue Regenix Group PLC(FRA:LSW)'s stock price today?
The current price of FRA:LSW is €0.70. The 52 week high of FRA:LSW is €0.88 and 52 week low is €0.56.
When is next earnings date of Tissue Regenix Group PLC(FRA:LSW)?
The next earnings date of Tissue Regenix Group PLC(FRA:LSW) is 2024-09-05 Est..
Does Tissue Regenix Group PLC(FRA:LSW) pay dividends? If so, how much?
Tissue Regenix Group PLC(FRA:LSW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers